These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 14703122)

  • 1. Benzimidazole derivatives. 4. The recognition of the voluminous substituent attached to the basic amino group of 5-HT4 receptor antagonists.
    López-Rodríguez ML; Benhamú B; Murcia M; Alvaro E; Campillo M; Pardo L
    J Comput Aided Mol Des; 2003 Aug; 17(8):515-24. PubMed ID: 14703122
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Benzimidazole derivatives. Part 1: Synthesis and structure-activity relationships of new benzimidazole-4-carboxamides and carboxylates as potent and selective 5-HT4 receptor antagonists.
    López-Rodríguez ML; Benhamú B; Viso A; Morcillo MJ; Murcia M; Orensanz L; Alfaro MJ; Martín MI
    Bioorg Med Chem; 1999 Nov; 7(11):2271-81. PubMed ID: 10632037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 2,3-Dihydro-2-oxo-1H-benzimidazole-1-carboxamides with selective affinity for the 5-HT(4) receptor: synthesis and structure-affinity and structure-activity relationships of a new series of partial agonist and antagonist derivatives.
    Tapia I; Alonso-Cires L; López-Tudanca PL; Mosquera R; Labeaga L; Innerárity A; Orjales A
    J Med Chem; 1999 Jul; 42(15):2870-80. PubMed ID: 10425096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Benzimidazole derivatives. 3. 3D-QSAR/CoMFA model and computational simulation for the recognition of 5-HT(4) receptor antagonists.
    López-Rodríguez ML; Murcia M; Benhamú B; Viso A; Campillo M; Pardo L
    J Med Chem; 2002 Oct; 45(22):4806-15. PubMed ID: 12383006
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative receptor mapping of serotoninergic 5-HT3 and 5-HT4 binding sites.
    López-Rodríguez ML; Morcillo MJ; Benhamú B; Rosado ML
    J Comput Aided Mol Des; 1997 Nov; 11(6):589-99. PubMed ID: 9491351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New esters of 4-amino-5-chloro-2-methoxybenzoic acid as potent agonists and antagonists for 5-HT4 receptors.
    Yang D; Soulier JL; Sicsic S; Mathé-Allainmat M; Brémont B; Croci T; Cardamone R; Aureggi G; Langlois M
    J Med Chem; 1997 Feb; 40(4):608-21. PubMed ID: 9046352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Benzimidazole derivatives as new serotonin 5-HT6 receptor antagonists. Molecular mechanisms of receptor inactivation.
    de la Fuente T; Martín-Fontecha M; Sallander J; Benhamú B; Campillo M; Medina RA; Pellissier LP; Claeysen S; Dumuis A; Pardo L; López-Rodríguez ML
    J Med Chem; 2010 Feb; 53(3):1357-69. PubMed ID: 20078106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 5-HT(4) receptor antagonists: structure-affinity relationships and ligand-receptor interactions.
    López-Rodriguez ML; Benhamú B; Morcillo MJ; Murcia M; Viso A; Campillo M; Pardob L
    Curr Top Med Chem; 2002 Jun; 2(6):625-41. PubMed ID: 12052197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and structure-activity relationships of potent and orally active 5-HT4 receptor antagonists: indazole and benzimidazolone derivatives.
    Schaus JM; Thompson DC; Bloomquist WE; Susemichel AD; Calligaro DO; Cohen ML
    J Med Chem; 1998 May; 41(11):1943-55. PubMed ID: 9599243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and 5-HT3 receptor affinity of new quinolinecarboxylic acid derivatives.
    Orjales A; Alonso-Cires L; López-Tudanca PL; Tapia I; Labeaga L; Mosquera R
    Drug Des Discov; 2000; 16(4):271-9. PubMed ID: 10807033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Benzimidazole derivatives. 2. Synthesis and structure-activity relationships of new azabicyclic benzimidazole-4-carboxylic acid derivatives with affinity for serotoninergic 5-HT(3) receptors.
    López-Rodríguez ML; Benhamú B; Morcillo MJ; Tejada ID; Orensanz L; Alfaro MJ; Martín MI
    J Med Chem; 1999 Dec; 42(24):5020-8. PubMed ID: 10585211
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New 2-piperazinylbenzimidazole derivatives as 5-HT3 antagonists. Synthesis and pharmacological evaluation.
    Orjales A; Mosquera R; Labeaga L; Rodes R
    J Med Chem; 1997 Feb; 40(4):586-93. PubMed ID: 9046349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acidic biphenyl derivatives: synthesis and biological activity of a new series of potent 5-HT(4) receptor antagonists.
    Brudeli B; Andressen KW; Moltzau LR; Nilsen NO; Levy FO; Klaveness J
    Bioorg Med Chem; 2013 Nov; 21(22):7134-45. PubMed ID: 24113240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery of TD-8954, a clinical stage 5-HT(4) receptor agonist with gastrointestinal prokinetic properties.
    McKinnell RM; Armstrong SR; Beattie DT; Fatheree PR; Long DD; Marquess DG; Shaw JP; Vickery RG
    Bioorg Med Chem Lett; 2013 Jul; 23(14):4210-5. PubMed ID: 23756062
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 3-D-QSAR/CoMFA and recognition models of benzimidazole derivatives at the 5-HT(4) receptor.
    López-Rodríguez ML; Murcia M; Benhamú B; Viso A; Campillo M; Pardo L
    Bioorg Med Chem Lett; 2001 Nov; 11(21):2807-11. PubMed ID: 11597405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of a series of 5-HT4 receptor agonists and antagonists on steroid secretion by the adrenal gland in vitro.
    Contesse V; Hamel C; Delarue C; Lefebvre H; Vaudry H
    Eur J Pharmacol; 1994 Nov; 265(1-2):27-33. PubMed ID: 7883026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Arylcarbamate derivatives of 1-piperidineethanol as potent ligands for 5-HT4 receptors.
    Soulier JL; Yang D; Brémont B; Croci T; Guzzi U; Langlois M
    J Med Chem; 1997 May; 40(11):1755-61. PubMed ID: 9171886
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New benzo[h][1,6]naphthyridine and azepino[3,2-c]quinoline derivatives as selective antagonists of 5-HT4 receptors: binding profile and pharmacological characterization.
    Hinschberger A; Butt S; Lelong V; Boulouard M; Dumuis A; Dauphin F; Bureau R; Pfeiffer B; Renard P; Rault S
    J Med Chem; 2003 Jan; 46(1):138-47. PubMed ID: 12502367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 5-HT(3)R binding of lerisetron: an interdisciplinary approach to drug-Receptor interactions.
    Parihar HS; Suryanarayanan A; Ma C; Joshi P; Venkataraman P; Schulte MK; Kirschbaum KS
    Bioorg Med Chem Lett; 2001 Aug; 11(16):2133-6. PubMed ID: 11514154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective, centrally acting serotonin 5-HT2 antagonists. 2. Substituted 3-(4-fluorophenyl)-1H-indoles.
    Andersen K; Perregaard J; Arnt J; Nielsen JB; Begtrup M
    J Med Chem; 1992 Dec; 35(26):4823-31. PubMed ID: 1336054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.